MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a progressive dementia characterized by altered processing of amyloid precursor protein (APP), formation of beta-amyloid plaques (Aβ), hyper-phosphorylated tau containing neurofibrillary tangles, and synaptic loss in the brain.